Marc beer is the co-founder and the CEO of a med-tech company, Renovia Inc. based in Boston. The health center specializes in the production of therapeutic and diagnostic products which treats a condition caused by pelvic floor disorders such as urinary incontinence. According to researchers’ statistics, approximately 250 million women in the world are believed to suffer from these disorders. On April 2018, FDA approved Leva which were the Renovia`s first product to be developed.
On August last year, Marc Beer led in raising the fund for the health care. The total fund raised added up to $42 million which was contributed in two phases. The first batch raised $10 million in venture debt while the second phase raised $32 million in Series B round. The funding will be used in development and testing of other four more diagnostic and therapeutic products as well as in the development of another generation of Leva devices.
The Longwood Fund, a healthcare related investment firm that had earlier invested in Renovia, joined the Series B funding, which was led by Perspective Advisors from New York and Ascension Ventures from Missouri.
The move was hailed positively from Renovia side. In a statement from Marc Beer, the CEO said that his team is thrilled by the support they have been receiving aimed at helping millions of women suffering from pelvic disorders. He added that through combining their innovative and proprietary sensors technology and creating common health platforms would help customers to access valuable data such as informing them of new treatment methods available, they will learn from them ways to handle pelvic floor disorders, and at the end, treatment cost will lower. The company failed to respond to questions about its investment or its pipeline products.
Renovia leadership team is headed by a group of experts in the various health sector who ensures customers need meet. Marc Beer being the Chairman and CEO, he works with other personnel who assists him to accomplish day to day activities. Prior to founding Renovia, Marc Beer worked for more than 25 years in commercializing and development of biotechnology, pharmaceuticals, and diagnostic devices. He together with Ramon Iglesias, MD and Yolanda Lorie are the founded Renovia in the year 2016.
William Dull is the Chief Commercial Officer of Renovia, and his primary role is to oversee international commercial and company`s operation. He joined Renovia from Aegerion Pharmaceutical where he developed innovative solutions which helped to solve complex patient problems. Dr. Samantha Pulliam served as the Chief Medical Officer and joined Renovia from the University of North Carolina where she was the Assistant Professor of Obstetrics and Gynecology. She has extensive experience in research where she has published over 50 peer-reviewed research papers and abstracts. Learn more: https://renoviainc.com/leadership/